超声造影在诊断心脏占位性病变中的应用价值

曾曦, 吕琼芳, 胡佳, 等. 超声造影在诊断心脏占位性病变中的应用价值[J]. 临床心血管病杂志, 2021, 37(8): 740-743. doi: 10.13201/j.issn.1001-1439.2021.08.013
引用本文: 曾曦, 吕琼芳, 胡佳, 等. 超声造影在诊断心脏占位性病变中的应用价值[J]. 临床心血管病杂志, 2021, 37(8): 740-743. doi: 10.13201/j.issn.1001-1439.2021.08.013
CENG Xi, LU: Qiongfang, HU Jia, et al. Application value of contrast-enhanced ultrasound in diagnosing cardiac masses[J]. J Clin Cardiol, 2021, 37(8): 740-743. doi: 10.13201/j.issn.1001-1439.2021.08.013
Citation: CENG Xi, LU: Qiongfang, HU Jia, et al. Application value of contrast-enhanced ultrasound in diagnosing cardiac masses[J]. J Clin Cardiol, 2021, 37(8): 740-743. doi: 10.13201/j.issn.1001-1439.2021.08.013

超声造影在诊断心脏占位性病变中的应用价值

  • 基金项目:

    江西省研究生创新专项基金资助项目(No:YC2019-S058)

详细信息
    通讯作者: 袁新春,E-mail:yespring97@163.com
  • 中图分类号: R445.1

Application value of contrast-enhanced ultrasound in diagnosing cardiac masses

More Information
  • 目的:探讨超声造影(contrast-enhanced ultrasound, CEUS)在心脏占位性病变中的诊断价值。方法:选取26例经常规经胸超声心动图(transthoracic echocardiography, TTE)发现心脏占位性病变的患者,均行TTE及CEUS检查,判断病变性质,分析TTE及CEUS检查的表现特点。结果:26例患者中有6例确诊为血栓,14例确诊为良性肿瘤及赘生物,6例确诊为恶性肿瘤。TTE检查结果确诊5例血栓、9例良性肿瘤及赘生物,误诊1例血栓为黏液瘤,其余11例未能定性。CEUS检查结果与手术病理及临床诊断结果相一致。良、恶性病变造影增强程度及灌注方式比较,差异均有统计学意义(均P<0.05)。结论:在诊断心脏占位性病变中,TTE根据病灶形态、边界及有无心包积液结合病史可做出初步诊断,CEUS根据造影剂增强程度及灌注方式可有助于鉴别血栓和肿瘤性病变、肿瘤性病变的良恶性,从而提高诊断的准确率。
  • 加载中
  • [1]

    Auger D,Pressacco J,Marcotte F,et al.Cardiac masses:an integrative approach using echocardiography and other imaging modalities[J].Heart,2011,97(13):1101-1109.

    [2]

    杨娅,何怡华,刘文旭.心脏肿瘤[M]王新房.超声心动图.4版,北京:人民卫生出版社,2009:526-540.

    [3]

    曹春莉,陈铭,杜婷婷,等.超声造影联合二维超声在TI-RADS 4类甲状腺结节良恶性鉴别诊断中的应用价值[J].实用医学杂志,2019,35(18):2954-2958.

    [4]

    陈彦玲,王文平.超声造影在肝细胞性肝癌诊疗中的应用进展[J].中华超声影像学杂志,2020,29(10):916-920.

    [5]

    Look Hong NJ,Pandalai PK,Hornick JL,et al.Cardiac angiosarcoma management and outcomes:20-year single-institution experience[J].Ann Surg Oncol,2012,19(8):2707-2715.

    [6]

    Poterucha TJ,Kochav J,O'Connor DS,et al.Cardiac tumors:clinical presentation,diagnosis,and management[J].Curr Treat Options Oncol,2019,20(8):66.

    [7]

    Bussani R,Castrichini M,Restivo L,et al.Cardiac tumors:diagnosis,prognosis,and treatment[J].Curr Cardiol Rep,2020,22(12):169.

    [8]

    Sarjeant JM,Butany J,Cusimano RJ.Cancer of the heart:epidemiology and management of primary tumors and metastases[J].Am J Cardiovasc Drugs,2003,3(6):407-421.

    [9]

    Singhal P,Luk A,Rao V,et al.Molecular basis of cardiac myxomas[J].Int J Mol Sci,2014,15(1):1315-1337.

    [10]

    Patel R,Lim RP,Saric M,et al.Diagnostic performance of cardiac magnetic resonance imaging and echocardiography in evaluation of cardiac and paracardiac masses[J].Am J Cardiol,2016,117(1):135-140.

    [11]

    汤乔颖,邓又斌,毕小军,等.声学造影对心脏占位病变性质的鉴别诊断价值[J].中华医学超声杂志(电子版),2019,16(10):742-748.

    [12]

    牛永红,王廉一,唐秀杰,等.心脏肿瘤的超声影像与手术病理对照分析[J].中国临床医学影像杂志,2020,31(3):184-187.

    [13]

    Xia H,Gan L,Jiang Y,et al.Use of transesophageal echocardiography and contrast echocardiography in the evaluation of cardiac masses[J].Int J Cardiol,2017,236:466-472.

    [14]

    Wang X,Li Y,Ren W,et al.Clinical diagnostic value of contrast-enhanced ultrasonography in the diagnosis of cardiac masses:A pilot study[J].Echocardiography,2020,37(2):231-238.

    [15]

    Shi Y,Duan S,Zhang L,et al.A primary benign cardiac tumor misdiagnosed as cardiac metastasis in the right atrium[J].Echocardiography,2020,37(10):1678-1681.

  • 加载中
计量
  • 文章访问数:  814
  • PDF下载数:  192
  • 施引文献:  0
出版历程
收稿日期:  2020-12-18

目录